top of page

Hemodynamics Management

Public·221 members

Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock (ECMO-CS) trial



  • The ECMO-CS trial was conducted to compare the effects of immediate implementation of VA-ECMO vs. an initially conservative therapy in patients with rapidly deteriorating or severe cardiogenic shock.

  • The primary endpoint was the composite of death from any cause, resuscitated circulatory arrest, and implementation of another mechanical circulatory support device at 30 days.

M B
ekseibi

Efficacy of Levosimendan in the Treatment of Patients with Severe Septic Cardiomyopathy



•Thirty patients with severe septic cardiomyopathy were enrolled in the study and randomly divided into the levosimendan group and dobutamine group.

• The primary outcome was 28-day mortality.

M B
M A
ekseibi
    bottom of page